Fry for the US Antiviral Resistance
Surveillance Working Group 
Pockros stressed, physicians must have a good understanding of the treatment regimens, particularly in special populations, and they must actively and frequently monitor for antiviral resistance
a patient from FluSurv-NET who had a pandemic (H1N1) 2009 virus specimen submitted to national antiviral resistance
surveillance who had an oseltamivir-susceptible pandemic (H1N1) 2009 virus infection.
Continued surveillance is important to inform clinicians and public health authorities regarding influenza prevalence, strains in communities, and changes in antiviral resistance
They added: "The emergency of oseltamivir resistance has highlighted the need for the development of new antiviral drugs and rapid diagnostic tests that determine viral subtype or resistance, as well as improved representativeness and timeliness of national influenza surveillance for antiviral resistance
Laboratory data suggest that NS5A inhibitors can potentially be used in combination with any of these other HCV agents, to achieve better efficacy in hepatitis C patients and combat the emergence of antiviral resistance
Multiple specimens were available from patients D, E, and G for analyzing antiviral resistance
mutations in NA.
Influenza antiviral resistance
is a growing clinical problem; as such, treatment recommendations are likely to change with time.
A new Cytomegalovirus (CMV) Antiviral Resistance
Test accurately detects in three days or less key genetic mutations associated with antiviral resistance
to CMV; most other tests' TAT is up to two weeks.
May 21 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that a Canadian team comprised of the Canada Research Chair in Medical Genomics, Professor Jacques Corbeil and Canada Research Chair on new viruses and antiviral resistance
, Professor Guy Boivin has used its enhanced respiratory virus panel assay to test for the presence of the new Flu A - Swine H1N1 virus.
The SeqHepB system and intellectual property emanates from the laboratory of Professor Stephen Locarnini, a world renowned expert in Hepatitis B and antiviral resistance
, from Melbourne Health (Melbourne, Australia).